Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02058524 · ClinicalTrials.gov registry record · Phase 1
A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative Colitis
A Phase 1 study, sponsored by University of Chicago.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT02058524 is a Phase 1 study that was terminated before completion, run by University of Chicago. The registered enrollment target is 1 participants.
The verdict
NCT02058524, a Phase 1 study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The investigators are conducting an open-label study of fecal microbiota transplantation (FMT) for adult patients with mildly-moderately active ulcerative colitis. In this pilot study the investigators will evaluate the feasibility, safety, and tolerability of a single application of FMT delivered colonoscopically. The investigators will also characterize the impact of FMT on the microbiota of the recipient and determine if it correlates with the microbiota from the FMT donor.
Interventions
- BIOLOGICAL fecal microbiota transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-06 |
| Est. Completion | 2016-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02058524
The ClinicalTrials.gov registry entry for NCT02058524 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fecal microbiota transplantation is the first listed.
NCT02058524 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02058524 about?
NCT02058524 is a clinical study titled "A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative Colitis". The investigators are conducting an open-label study of fecal microbiota transplantation (FMT) for adult patients with mildly-moderately active ulcerative colitis. In this pilot study the investigators will evaluate the feasibility, safety, and tolerability of a single application of FMT delivered c...
What is the current status of trial NCT02058524?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2013-06. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02058524?
The interventions under investigation include: fecal microbiota transplantation (BIOLOGICAL).
Who is sponsoring clinical trial NCT02058524?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.